Keyphrases
Osteosarcoma
100%
Lung Metastasis
96%
Osteosarcoma Cells
69%
Signaling Pathway
48%
Lung
43%
Tumor
41%
Apoptosis
40%
Lung Microenvironment
39%
Novel Therapeutics
37%
MiR-20a
35%
Fas Ligand
26%
Metastatic Process
26%
Metastasis
24%
Promoter Activity
24%
Doxorubicin
24%
Metabolic Reprogramming
24%
Ewing Sarcoma
24%
Pericyte Coverage
24%
Vascular Pericytes
24%
Pramlintide
24%
Hippo-YAP
24%
RE1-silencing Transcription Factor
24%
Vessel Perfusion
24%
Repressor
24%
FasL
24%
Induced Damage
24%
CDC1
24%
CD103
24%
Dendritic Cell-based Immunotherapy
24%
Fas Expression
22%
Gemcitabine
19%
Tumor Growth
14%
Metastasizing
14%
Lymph Node
12%
Fas Signaling Pathway
10%
Aerosol
10%
Human Islet Amyloid Polypeptide (hIAPP)
10%
Tumor Regression
9%
T Cells
9%
Spleen
9%
Anti-CTLA-4
9%
Tumor Cells
7%
Entinostat
7%
Therapeutic Potential
7%
Cell Surface
7%
Glycolysis
6%
Glycolytic Activity
6%
Bone Marrow Cells
6%
Anti-miR
6%
Tumor-draining Lymph Nodes
6%
Medicine and Dentistry
Lung Metastasis
72%
Osteosarcoma
72%
Lung
50%
Cell Signaling Pathway
48%
Neoplasm
33%
Programmed Cell Death
30%
Pericyte
27%
Metastatic Carcinoma
26%
Fas Ligand
26%
Repressor Gene
24%
Doxorubicin
24%
Ewing Sarcoma
24%
Dendritic Cell Vaccine
24%
Osteosarcoma Cell
23%
Transcription Factor
21%
Gemcitabine
14%
Lymph Node
13%
Upregulation
10%
Tumor Progression
9%
microRNA 20a
8%
Tumor Cell
8%
T Cell
6%
Entinostat
5%
Biochemistry, Genetics and Molecular Biology
Programmed Cell Death
58%
Upregulation
49%
Gemcitabine
36%
Fas Ligand
32%
Pericyte
27%
Angiogenesis
25%
Cell Survival
24%
Perfusion
24%
Promoter Region
24%
Ewing Sarcoma
24%
Repressor
24%
Doxorubicin
24%
Transcription Factor
21%
Proteomics
16%
Downregulation
14%
Untranslated Region
14%
Messenger RNA
14%
Tumor Progression
12%
Histone Deacetylase
11%
MicroRNA
11%
Fibrinogen
8%
Secretome
8%
Protein Expression Level
8%
Overall Survival
8%
Cell Surface Protein
8%
Mouse Model
8%
Vascular Endothelial Growth Factor
8%
Platelet-Derived Growth Factor
8%